We have no reason, however, to suspect that there was any sex difference in this respect, so that our comparisons between men and women were unlikely to have been seriously affected by this source of error.
Patients and methods
Patients with duodenal ulcer were treated with cimetidine Ig daily until the ulcer had healed; ulceration and healing were confirmed by endoscopy. The drug was then stopped. If minor symptoms such as slight heartburn or upper abdominal discomfort continued or recurred the patients were advised to use small amounts of antacids. If, however, their symptoms became troublesome they came back to see me and after assessment received a second course of cimetidine. This was repeated for a third time if a further relapse occurred. In most patients cimetidine for one to two months produced healing. During most relapses endoscopy was repeated to confirm both ulceration and healing before the cimetidine was begun again and stopped. In 10 episodes, however, this was not possible. These patients are nevertheless included for analysis because they had a recurrence of typical symptoms that almost invariably indicated reulceration.3
The patients' progress was followed up for up to 22 months, after which time those who had not recently had a relapse were recalled for interview. The pattern of relapse and remission was examined. The remission period was arbitrarily taken to be the period when the patients were not taking cimetidine.
Results
One hundred and twenty-five patients were treated until the ulcer healed. During the next 22 months 83 patients relapsed (fig 1) . After six months 48 patients (38%) had relapsed including five (4%) in less than one month, but 53 patients (42%) were in clinical remission for over one year. Of the patients who relapsed, 21 defaulted. The remaining 62 patients were retreated, but 36 relapsed again. Of these, 29 (470o) had relapsed by six months including five (8%) in less than one month, but 29 (47%) were asymptomatic for over a year (fig 2) . The pattern of the second relapse was similar to that of the first.
From these data the probability that a patient would remain in remission after treatment with cimetidine was calculated by lifetime analysis (fig 3) . The results after one and two short courses of cimetidine are similar, indicating that the natural history of the disease is unchanged. Figure 3 may be used in general practice, where most patients with ulcers are seen.
Secondly, intermittent treatment is more economical: less drug is required than for maintenance treatment. Assuming that on average a six-week course of cimetidine lg daily is required to heal a duodenal ulcer and provided that there are no contraindications, for 100 patients treated intermittently during one year about 200 courses would be required. The trade price of cimetidine is £,;13 22 per hundred 200-mg tablets, excluding dispensing fees:; based on this figure the drug cost for such treatment is therefore about C5500. (I have excluded any costs incurred owing to a delay in restarting treatment, leading to worsening of symptoms and loss of time at work, or to the occurrence of haemorrhage or perforation.) In contrast, if after initial treatment these patients are put on prophylactic low-dose maintenance treatment with cimetidine 400 mg nightly for a year, and allowing for 13% to have a symptomatic relapse' requiring retreatment with full doses of cimetidine, the drug cost is about £12 600. Therefore, though maintenance treatment (or surgery) is the onily suitable method of treating several patients, in most cases intermittent treatment provides a cheaper method of obtaining satisfactory results.
Thirdly, patients who rapidly and repeatedly relapse each time cimetidine is withdrawn are easily recognised; they may confidently be selected for maintenance treatment or surgery.
In conclusion, given the uncertainties of long-term low-dose maintenance treatment with cimetidine, intermittent treatment provides a reasonable alternative for the longer-term treatment of most patients. Obstetric epidural analgesia and postural hypotension E MOSS, R MACDONALD Summary and conclusions Supine and erect arterial pressures were measured daily for six to seven days after delivery In 100 patients, of whom 50 had received epidural analgesia. There was no difference in the magnitude of postural hypotension between the epidural and control groups on any day after delivery, although in both groups the hypotension was greater during the first two days due almost entirely to changes in systolic arterial pressure. The incidence of dizziness on standing was similar in both groups (9%).
Thus postural hypotension is no more common in women who have received epidural analgesia than in others. All patients should be helped out of bed after delivery, and any patient who experiences dizziness should have her blood pressure measured until the dizziness disappears.
Introduction
Briggs et all reported a case of persistent severe postural hypotension after lumbar epidural analgesia during labour in a 26-year-old woman. They attributed this hypotension, which was still present three months after she received the analgesia, to an idiosyncratic reaction to bupivacaine causing a prolonged sympathetic block. To establish whether this case was just an exaggeration of a normal finding or was unique we undertook a study to determine the incidence of postural hypotension in the first week after delivery in patients who had received epidural analgesia for pain relief in labour.
Patients and methods
We studied 100 patients, of whom 50 received continuous lumbar epidural analgesia during labour (epidural group); the remaining 50 received pethidine or nitrous oxide, or both, if they required analgesia (control group). Only patients booked for a 10-day stay in hospital were included in the study. No patient lost more than 200 ml of blood. Patients in the control group were chosen to match as closely as possible the age, parity, duration of labour, and date of delivery of patients in the epidural group.
Arterial pressure was measured daily until discharge in each
